These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33469675)

  • 21. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system.
    Zhang X; Dong Y; Zhao M; Ding L; Yang X; Jing Y; Song Y; Chen S; Hu Q; Ni Y
    Theranostics; 2020; 10(26):12044-12059. PubMed ID: 33204328
    [No Abstract]   [Full Text] [Related]  

  • 23. Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner.
    Park S; Kim S; Kim MY; Lee SS; Choi J
    Oncol Rep; 2024 Oct; 52(4):. PubMed ID: 39155881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.
    Kang Y; Zhang Y; Sun Y
    Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPT1 Promotes Growth and Inhibits Ferroptosis of Oral Squamous Cell Carcinoma Cells.
    Luo Q; Hu S; Tang Y; Yang D; Chen Q
    Curr Cancer Drug Targets; 2024; 24(10):1047-1060. PubMed ID: 38299399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab‑resistant oral squamous cell carcinoma.
    Tsuchihashi H; Naruse T; Yanamoto S; Okuyama K; Furukawa K; Omori K; Umeda M
    Oncol Rep; 2020 Sep; 44(3):863-872. PubMed ID: 32705230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-146b Functions as an Oncogene in Oral Squamous Cell Carcinoma by Targeting HBP1.
    Li K; Zhou Z; Li J; Xiang R
    Technol Cancer Res Treat; 2020; 19():1533033820959404. PubMed ID: 33327874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.
    Grismayer B; Sölch S; Seubert B; Kirchner T; Schäfer S; Baretton G; Schmitt M; Luther T; Krüger A; Kotzsch M; Magdolen V
    Mol Cancer; 2012 Aug; 11():62. PubMed ID: 22920728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
    Zhai J; Luo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 35. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
    Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
    Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of ACTL6A leads to poor prognosis of oral squamous cell carcinoma patients through promoting malignant progression.
    Liu Y; Liu Y; Li Y; Wang T; Li B; Kong X; Li C
    Head Neck; 2024 Jun; 46(6):1450-1467. PubMed ID: 38523407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
    Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
    Lyu Q; Jin L; Yang X; Zhang F
    Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
    Wang CI; Kao HK; Chen TW; Huang Y; Cheng HW; Yi JS; Hung SY; Wu CS; Lee YS; Chang KP
    Oncologist; 2019 Dec; 24(12):e1388-e1400. PubMed ID: 31273053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.